Reprogramming NK cells and macrophages via combined antibody and cytokine therapy primes tumors for elimination by checkpoint blockade-Reference-Cited by-同舟云学术

Reprogramming NK cells and macrophages via combined antibody and cytokine therapy primes tumors for elimination by checkpoint blockade

Published:2021-11 Issue:8 Volume:37 Page:110021
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Wang Chensu,Cui Ang^ORCID,Bukenya Maurice^ORCID,Aung Aereas,Pradhan Dikshant,Whittaker Charles A.,Agarwal Yash^ORCID,Thomas Ayush,Liang Simon^ORCID,Amlashi Parastoo^ORCID,Suh Heikyung,Spranger Stefani,Hacohen Nir,Irvine Darrell J.

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference106 articles.

1. CCL3 augments tumor rejection and enhances CD8+ T cell infiltration through NK and CD103+ dendritic cell recruitment via IFNγ;Allen;Oncoimmunology,2017

2. CD38 Is Robustly Induced in Human Macrophages and Monocytes in Inflammatory Conditions;Amici;Front. Immunol.,2018

3. Differential expression analysis for sequence count data;Anders;Genome Biol.,2010

4. Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer;Antonia;N. Engl. J. Med.,2017

5. Trastuzumab-based treatment of HER2-positive breast cancer: an antibody-dependent cellular cytotoxicity mechanism?;Arnould;Br. J. Cancer,2006

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Local delivery of cell surface-targeted immunocytokines programs systemic antitumor immunity;Nature Immunology;2024-08-07

2. Tumor-Localized Interleukin-2 and Interleukin-12 Combine with Radiation Therapy to Safely Potentiate Regression of Advanced Malignant Melanoma in Pet Dogs;Clinical Cancer Research;2024-07-09

3. T cell cascade regulation initiates systemic antitumor immunity through living drug factory of anti-PD-1/IL-12 engineered probiotics;Cell Reports;2024-04

4. Tumor-localized interleukin-2 and interleukin-12 combine with radiation therapy to safely potentiate regression of advanced malignant melanoma in pet dogs;2024-02-14

5. β-Glucan–conjugated anti–PD-L1 antibody enhances antitumor efficacy in preclinical mouse models;Carbohydrate Polymers;2024-01